Stockscreener 앱 받기
2.19
3.91%
-0.11
전일 마감가:
$2.30
열려 있는:
$2.24
하루 거래량:
26,978
Relative Volume:
0.02
시가총액:
$3.96M
수익:
$12.31M
순이익/손실:
$-5.08M
주가수익비율:
-2.3298
EPS:
-0.94
순현금흐름:
$-5.20M
1주 성능:
-9.80%
1개월 성능:
-36.49%
6개월 성능:
-25.59%
1년 성능:
-26.33%
1일 변동 폭
$2.20
$2.29
1주일 범위
$2.20
$2.749
52주 변동 폭
$1.75
$9.374
소노마 파머 Stock (SNOA) Company Profile
명칭
Sonoma Pharmaceuticals Inc
전화
800-759-9305
주소
5445 CONESTOGA COURT, SUITE 150, BOULDER, CA
SNOA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SNOA
Sonoma Pharmaceuticals Inc
|
2.25 | 3.96M | 12.31M | -5.08M | -5.20M | -0.94 |
|
ZTS
Zoetis Inc
|
145.54 | 67.28B | 9.26B | 2.49B | 2.30B | 5.47 |
|
HLN
Haleon Plc Adr
|
10.14 | 45.61B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.82 | 45.01B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
13.30 | 15.64B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
282.58 | 12.77B | 2.76B | 1.11B | 898.10M | 22.77 |
소노마 파머 주식(SNOA)의 최신 뉴스
NovoCure (NASDAQ:NVCR) vs. Sonoma Pharmaceuticals (NASDAQ:SNOA) Financial Review - Defense World
Analyzing Inspira Technologies Oxy B.H.N. (NASDAQ:IINN) and Sonoma Pharmaceuticals (NASDAQ:SNOA) - Defense World
SNOA stock touches 52-week low at $1.84 amid market challenges - Investing.com Australia
SNOA stock touches 52-week low at $1.84 amid market challenges By Investing.com - Investing.com South Africa
Head to Head Survey: DarioHealth (NASDAQ:DRIO) & Sonoma Pharmaceuticals (NASDAQ:SNOA) - Defense World
Delaware passes law designed to stop more Elon Musks from leaving state - Yahoo Finance
Fast-paced Momentum Stock Sonoma Pharmaceuticals (SNOA) Is Still Trading at a Bargain - Yahoo Finance
Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Sees Significant Growth in Short Interest - Defense World
Sonoma Pharmaceuticals expands agreement with WellSpring By Investing.com - Investing.com Australia
Sonoma Pharmaceuticals expands agreement with WellSpring - Investing.com
Layoff Tracker: Vaxart Cuts 10% of Staff After US Government Orders Vaccine Trial Halt - BioSpace
Sonoma Pharmaceuticals (NASDAQ:SNOA) Stock Crosses Above 200 Day Moving Average – Here’s Why - Defense World
FDA Lifts Clinical Hold, vTv Therapeutics (VTVT) Stock Surges - Stocks Telegraph
Breakthrough Approval Sends Monogram Technologies (MGRM) Shares Soaring - Stocks Telegraph
Sonoma Pharmaceuticals (SNOA) Gains In Pre-Hour Trading - Stocks Telegraph
Pre-market Movers: REVB, QSI, EYEN, NAOV ... - RTTNews
Scar Management Market Top PlayersNewmedical Technology - openPR.com
Why Fast-paced Mover Sonoma Pharmaceuticals (SNOA) Is a Great Choice for Value Investors - Yahoo Finance
Why Paymentus Holdings Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket - Benzinga
SNOA's Wound Care Products Get Regulatory Clearance, LFMD's Q4 Revenue Soars, ATRA On Watch - RTTNews
Sonoma Pharmaceuticals expands into UK market By Investing.com - Investing.com Australia
Sonoma Pharmaceuticals expands into UK market - Investing.com India
Sonoma Pharmaceuticals Secures Extensive U.K. Regulatory Clearances of Key Wound Care and Dermatology Products by the Medicines & Healthcare Products Regulatory Agency (MHRA) - ACCESS Newswire
Why Checkpoint Therapeutics Shares Are Trading Higher By Around 66%; Here Are 20 Stocks Moving Premarket - Benzinga
Market Cool On Sonoma Pharmaceuticals, Inc.'s (NASDAQ:SNOA) Revenues Pushing Shares 25% Lower - Simply Wall St
SNOA stock touches 52-week low at $2 amid market challenges - Investing.com Australia
SNOA stock touches 52-week low at $2 amid market challenges By Investing.com - Investing.com South Africa
Sonoma Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire
Scar Treatment Market Projected To Witness Massive Growth, - openPR
Addex Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:ADXN - Benzinga
Virpax Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:VRPX - Benzinga
Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn(R) Disinfectant & Sanitizer has been Approved by the Australian TGA as Effective Against Candida auris and C-Diff - ACCESS Newswire
SNOA Stock Touches 52-Week Low at $2.29 Amid Market Challenges By Investing.com - Investing.com South Africa
SNOA Stock Touches 52-Week Low at $2.29 Amid Market Challenges - Investing.com
Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando - ACCESS Newswire
How Sonoma Pharmaceuticals Plans to Expand Its Dermatology Footprint at Major 2025 Industry Event - StockTitan
Investor Network: Sonoma Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire
Sonoma Pharmaceuticals secures new supply agreement - MSN
SNOA stock touches 52-week low at $2.44 amid market challenges - Investing.com Canada
Sonoma County earmarks opioid settlement money for treatment, education programs - MSN
More Musk-like 'Dexits' pose fresh threat to Delaware's corporation crown - Yahoo Finance
CNS Pharma (NASDAQ:CNSP) Stock Quotes, Forecast and News Summary - Benzinga
Head-To-Head Survey: Sonoma Pharmaceuticals (NASDAQ:SNOA) and BrainsWay (NASDAQ:BWAY) - Defense World
Redhill Biopharma (NASDAQ:RDHL) Stock Quotes, Forecast and News Summary - Benzinga
Head-To-Head Survey: Sonoma Pharmaceuticals (NASDAQ:SNOA) vs. Femasys (NASDAQ:FEMY) - Defense World
소노마 파머 (SNOA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.71%
자본화:
|
볼륨(24시간):